基于SEER的头骨底部胆瘤的条件生存分析的实时预后预测
Xiaojia Zhang1, Xiaosheng Chen1, Jiajie Gu1
1Department of Neurosurgery, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
Translational cancer research
|October 29, 2025
概括
条件生存 (CS) 分析提高了骨底瘤 (SBC) 患者的预后准确度. 一种新的CS-nomogram提供了动态的,个性化的生存预测,增强了临床决策和患者咨询,以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
背景情况:
- 头骨底部胆瘤 (SBC) 是一种罕见的,具有攻击性的骨瘤,预后不佳,复发率高.
- 目前的生存分析是静态的,并没有捕捉随着时间的推移而变化的生存概率.
- 手术和放射治疗 (RT) 的进步改善了结果,但长期生存仍然不确定.
研究的目的:
- 应用条件生存 (CS) 分析来精确评估SBC患者不断变化的生存率.
- 开发第一个SBC特定的CS-nomogram,用于动态的,个性化的生存预测.
- 改善SBC患者的临床决策和患者咨询.
主要方法:
- 利用了来自SEER数据库的717名SBC患者 (2000-2019) 的数据.
- 应用CS分析来评估生存概率,并开发了一个SBC特定的CS-nomogram.
- 使用LASSO和多变量考克斯分析结合了关键临床病理因素;使用培训和验证队列验证了名录.
主要成果:
- 脑脊髓分析表明,随着时间的推移,SBC患者的整体存活率 (OS) 稳步改善.
- 10年后的OS概率从诊断时的61%增加到9年后的98%.
- 结合八个因素的CS-nomogram显示出强大的预测准确性 (C指数0.703培训,0.731验证) 具有良好的校准和临床效益.
结论:
- 一个结合CS分析和名图的新工具为SBC患者提供了动态的,个性化的生存预测.
- 该CS-nomogram增强预后评估和临床决策.
- 这个工具为长期SBC幸存者提供了更好的希望和精确的预后见解.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Actuarial Approach
284
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
284
Kaplan-Meier Approach
556
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
556
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Introduction To Survival Analysis
738
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
738
Assumptions of Survival Analysis
391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391


